Skip to the page

Data / Form D filings / Afaxys, Inc.

Afaxys, Inc.: Form D filings

Afaxys, Inc., a pharmaceuticals company in Charleston, SC, filed 4 Form D notices with the SEC between 2010 and 2025. The latest, on July 14, 2025, reports an offering of $5 million with nothing sold yet.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
701 E. BAY STREET, SUITE 402, Charleston, SC, 29403
Phone
(843) 577-0703
Industry
Pharmaceuticals
Entity type
Other (Public Benefit Corporation)
Incorporated in
Delaware
Revenue range
$5,000,001 - $25,000,000
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1503981

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jul 14, 2025New notice$5,000,000$0$5,000,0000Yet to occursec.gov
Jun 28, 2023New notice$46,847,984$0$46,847,9840Jun 27, 2023sec.gov
Jan 4, 2023New notice$50,000,000$0$50,000,0000Yet to occursec.gov
Oct 21, 2010New notice$6,600,000$0$6,600,0000Yet to occursec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Natasha K GiordanoDirector
Vince K RussellDirector
Rod K MarkinDirector
Joan K NeuschelerDirector
Stacy K CrossDirector
Ronda K DeanExecutive Officer, Director
Sarah K StoeszDirector

Every Form D from the week of Jul 14, 2025 · All recent filings in South Carolina · All recent Pharmaceuticals filings

Read from SEC EDGAR. Amount sold is what Afaxys, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.